Quick Answer
HNO International, Inc. reported Total Revenue of $65.6 thousand for fiscal year 2025.
HNO International, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $65.6K +1445.9% |
$4.2K -67.4% |
$13.0K -62.3% |
$34.5K | — |
| Net Income | -$6.62M -98.2% |
-$3.34M -73.2% |
-$1.93M -79.9% |
-$1.07M | — |
| Diluted EPS | -$0.04 -300.0% |
-$0.01 +0.0% |
-$0.01 +0.0% |
-$0.01 | — |
| Total Assets | $1.73M +38.6% |
$1.25M -1.1% |
$1.26M +1005.2% |
$114.3K | — |
| Cash and Equivalents | $9.5K -53.0% |
$20.3K -91.4% |
$235.2K +360.1% |
$51.1K | — |
| Stockholders Equity | -$1.63M -16.6% |
-$1.40M -623.7% |
-$193.1K +82.6% |
-$1.11M -2738.9% |
-$39.1K |
| Operating Income | -$6.62M -98.2% |
-$3.34M -73.2% |
-$1.93M -79.9% |
-$1.07M | — |
| Gross Profit | $65.6K +11755.5% |
$553.00 -92.2% |
$7.1K +5.3% |
$6.8K | — |
| Shares Outstanding | 100.80M -76.0% |
419.44M +0.0% |
419.34M +298.4% |
105.27M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | January 31, 2026 | $0.00 | — | — |
| Net Income | January 31, 2026 | -$182.1K | +96.7% | +63.4% |
| Diluted EPS | January 31, 2026 | $0.00 | +100.0% | +100.0% |
| Total Assets | January 31, 2026 | $1.39M | +0.3% | -19.7% |
| Cash and Equivalents | January 31, 2026 | $81.5K | +70.1% | +755.6% |
| Stockholders Equity | January 31, 2026 | -$1.70M | +3.1% | -4.1% |
| Operating Income | January 31, 2026 | -$182.1K | +96.7% | +63.4% |
| Gross Profit | January 31, 2026 | $0.00 | — | — |
| Shares Outstanding | December 31, 2026 | 101.82M | — | +0.0% |
- HNO International, Inc. reported Total Revenue of $65.6 thousand for fiscal year 2025.
- HNO International, Inc. showed an increase of +1445.9% in Total Revenue compared to the prior fiscal year.
- HNO International, Inc. reported Net Income of -$6.62 million for fiscal year 2025.
- HNO International, Inc. showed a decrease of -98.2% in Net Income compared to the prior fiscal year.
- HNO International, Inc. reported Diluted EPS of $0.04 per share (loss) for fiscal year 2025.
- HNO International, Inc. showed a decrease of -300.0% in Diluted EPS compared to the prior fiscal year.
- HNO International, Inc. reported Total Assets of $1.73 million for fiscal year 2025.
- HNO International, Inc. showed an increase of +38.6% in Total Assets compared to the prior fiscal year.
- HNO International, Inc. reported Cash and Equivalents of $9.5 thousand for fiscal year 2025.
- HNO International, Inc. showed a decrease of -53.0% in Cash and Equivalents compared to the prior fiscal year.
- HNO International, Inc. reported Stockholders Equity of -$1.63 million for fiscal year 2025.
- HNO International, Inc. showed a decrease of -16.6% in Stockholders Equity compared to the prior fiscal year.
- HNO International, Inc. reported Operating Income of -$6.62 million for fiscal year 2025.
- HNO International, Inc. showed a decrease of -98.2% in Operating Income compared to the prior fiscal year.
- HNO International, Inc. reported Gross Profit of $65.6 thousand for fiscal year 2025.
- HNO International, Inc. showed an increase of +11755.5% in Gross Profit compared to the prior fiscal year.
- HNO International, Inc. reported Shares Outstanding of 100.80 million shares for fiscal year 2025.
- HNO International, Inc. showed a decrease of -76.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: